![Ginger M. More](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ginger M. More
Directeur/Membre du Conseil chez
Alkermes, Inc.
Profil
Ginger M.
More is currently a Special Limited Partner of Oak Investment Partners (“Oak”) and had been a General Partner or Managing Member since 1980.
Oak has raised ten venture capital partnerships with a total of $4.2 billion in committed capital.
Oak has sponsored over 350 companies with aggregate annual revenues in excess of $100 billion.
Oak’s most recent fund, Oak X, was closed on February 28, 2001 with a total capitalization of $1.6 billion.
Ginger joined Oak at its inception in 1978 after ten years at Wright Investor's Service.
She has sponsored investments in and/or served on the boards of numerous healthcare and information technology companies including the following publicly-traded companies, Alexion Pharmaceuticals, Inc., Alkermes, Inc., Compaq Computer Corporation, Dyax Corporation, Esperion Therapeutics, Inc., Genzyme Corporation, Octel Communications Corporation, OraPharma, Inc., Osteotech Inc., Pharmacopeia, Inc. and Ribozyme Pharmaceuticals, Inc. Ginger studied Mathematics at the University of Bridgeport and became a Chartered Financial Analyst in 1978.
Postes actifs de Ginger M. More
| Sociétés | Poste | Début |
|---|---|---|
KBL Healthcare Ventures
 KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medical devices, healthcare services and medical information technology. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Directeur/Membre du Conseil | - |
Anciens postes connus de Ginger M. More
| Sociétés | Poste | Fin |
|---|---|---|
KBL Healthcare Acquisition Corp. III
 KBL Healthcare Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Directeur/Membre du Conseil | 10/08/2009 |
Oak Investment Partners
 Oak Investment Partners Investment ManagersFinance Oak Investment Partners invests in companies located in the United States. The firm targets companies operating in the fields of information technology, internet & consumer, financial services, healthcare information & services and clean energy sectors. It participates in early stage capital requirements. | Corporate Officer/Principal | - |
Oak Investment Partners
Oak Investment Partners Investment ManagersFinance Oak Investment Partners invests in companies located in the United States. The firm targets companies operating in the fields of information technology, internet & consumer, financial services, healthcare information & services and clean energy sectors. It participates in early stage capital requirements. | Private Equity Investor | 31/12/2001 |
Optherion, Inc.
 Optherion, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products | Directeur/Membre du Conseil | - |
Osteotech, Inc.
 Osteotech, Inc. Medical SpecialtiesHealth Technology Processes and develops human bone and bone connective tissue products | Corporate Officer/Principal | - |
Formation de Ginger M. More
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
49
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Compaq Computer Corp.
 Compaq Computer Corp. Computer Processing HardwareElectronic Technology Develops and manufactures a wide range of personal computing products | Electronic Technology |
Osteotech, Inc.
Osteotech, Inc. Medical SpecialtiesHealth Technology Processes and develops human bone and bone connective tissue products | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and produces drugs for oral diseases | Health Technology |
Esperion Therapeutics, Inc.
 Esperion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers biopharmaceutical products | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
Tengion, Inc.
 Tengion, Inc. BiotechnologyHealth Technology Develops new human organs and tissues | Health Technology |
KBL Healthcare Acquisition Corp. III
KBL Healthcare Acquisition Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
Optherion, Inc.
Optherion, Inc. Medical SpecialtiesHealth Technology Develops therapeutic products | Health Technology |
Oak Investment Partners
Oak Investment Partners Investment ManagersFinance Oak Investment Partners invests in companies located in the United States. The firm targets companies operating in the fields of information technology, internet & consumer, financial services, healthcare information & services and clean energy sectors. It participates in early stage capital requirements. | Finance |
University of Bridgeport
 University of Bridgeport Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KBL Healthcare Ventures
KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare invests in companies located in the United States. The firm targets companies operating in the fields of life sciences, medical devices, healthcare services and medical information technology. It provides financing for early stage capital requirements. | Finance |
The University of Connecticut Research & Development Corp.
 The University of Connecticut Research & Development Corp. Miscellaneous Commercial ServicesCommercial Services Provides information on research and development of technologies | Commercial Services |
Crossroads Venture Group, Inc.
 Crossroads Venture Group, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a trade association that connects venture investment professionals with companies | Commercial Services |
